1. Comparison of features and outcomes between HIV‐negative patients with Cryptococcus gattii meningitis and Cryptococcus neoformans meningitis in South China.
- Author
-
Su, Xiao‐Hong, Li, Wei‐Peng, Liu, Jun‐Yu, Wang, Yi‐Jie, Liu, Jia, Xu, Xiao‐Feng, Yang, Lu, Xia, Han, Jiang, Ying, and Peng, Fu‐Hua
- Subjects
- *
CRYPTOCOCCUS neoformans , *CRYPTOCOCCUS , *MENINGITIS , *NUCLEOTIDE sequencing , *CEREBROSPINAL fluid , *INTRACRANIAL pressure , *LUNGS - Abstract
Objectives: The objective of this study is to compare the epidemiologic, clinical, laboratory, and imaging features, and outcomes in patients with Cryptococcus gattii meningitis (CGM) and Cryptococcus neoformans meningitis (CNM). Methods: We performed a retrospective study of HIV‐negative patients with CGM and CNM (2015–2021) distinguished by metagenomic next‐generation sequencing in cerebrospinal fluid in South China. Results: A total of 81 patients (17 CGM, 64 CNM) were enrolled (72.8% male, median age 49 years, range 21–77 years), and CGM patients were younger (median, 43 vs 53 years, p =.005). Of 17 CGM, VGI and VGII accounted for 70.6% and 29.4%, respectively. CGM patients had less underlying diseases (7/17 [41.2%] vs 48/64 [75%], p =.018) and focal neurologic deficit (3/17 [17.6%] vs 35/64 [54.7%], p =.022), had higher intracranial pressure (15/17 [88.2%] vs 25/64 [39.1%], p =.002), more meningeal enhancement (14/17 [82.4%] vs 32/64 [50%], p =.034), less parenchymal involvement (median, 1 vs 3, p =.018), more lung cryptococcomas (6/12 [50%] vs 6/47 [12.8%], p =.014), faster CSF fungal clearance (p =.004), less complications (median, 1 vs 3, p <.001), and more favourable outcomes (16/17 [94.1%] vs 41/64 [64.1%], p =.035). Conclusions: This study demonstrated that species identification helps to guide therapy and predict outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF